<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - MOMETASONE FUROATE</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>MOMETASONE FUROATE</h1>

        <p><a href="../drugClass/PHP34650.html">CORTICOSTEROIDS (INHALED)</a><a href="../drugClass/PHP34550.html">CORTICOSTEROIDS (TOPICAL)</a><a href="../drugClass/PHP34648.html">CORTICOSTEROIDS (INTRANASAL)</a></p>

      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#patientAndCarerAdvice" data-toggle="tab">Patient and carer advice</a></li>
          <li><a href="#nationalFunding" data-toggle="tab">National funding/access decisions</a></li>
          <li><a href="#unlicensedUse" data-toggle="tab">Unlicensed use</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Prophylaxis of asthma</span>,
            </h4>
            <p class="specificity"><span class="route">By inhalation of powder</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 400 micrograms daily in 1&#8211;2 divided doses, single dose to be inhaled in the evening, reduced to 200 micrograms once daily, if control maintained.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                Initially 400 micrograms daily in 1&#8211;2 divided doses, single dose to be inhaled in the evening, reduced to 200 micrograms once daily, if control maintained.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Prophylaxis of severe asthma</span>,
            </h4>
            <p class="specificity"><span class="route">By inhalation of powder</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Increased if necessary up to 400 micrograms twice daily.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                Increased if necessary up to 400 micrograms twice daily.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids</span>,
                <span class="indication">Psoriasis</span>,
            </h4>
            <p class="specificity"><span class="route">To the skin</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Apply once daily, to be applied thinly (to scalp in case of lotion).</li>
              <li class="dose child"><strong>For children 2&#8211;17 years</strong><br/>
                Apply once daily, to be applied thinly (to scalp in case of lotion).</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Prophylaxis and treatment of allergic rhinitis</span>,
            </h4>
            <p class="specificity"><span class="route">By intranasal administration</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                100 micrograms daily, increased if necessary up to 200 micrograms daily, dose to be sprayed into each nostril; reduced to 50 micrograms daily, dose to be reduced when control achieved, dose to be sprayed into each nostril.</li>
              <li class="dose child"><strong>For children 6&#8211;11 years</strong><br/>
                50 micrograms daily, dose to be sprayed into each nostril.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                100 micrograms daily, increased if necessary up to 200 micrograms daily, dose to be sprayed into each nostril; reduced to 50 micrograms daily, dose to be reduced when control achieved, dose to be sprayed into each nostril.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Nasal polyps</span>,
            </h4>
            <p class="specificity"><span class="route">By intranasal administration</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 100 micrograms daily for 5&#8211;6 weeks, dose to be sprayed into each nostril, then increased if necessary to 100 micrograms twice daily, dose to be sprayed into each nostril, consider alternative treatment if no improvement after further 5&#8211;6 weeks, reduce to the lowest effective dose when control achieved.</li>
            </ul>
          </section>
        </section>
        
        
        
        
        
            <section class="potency">
              <h3>Potency of preperations</h3>
              <p>Mometasone furoate 0.1% cream, ointment, and scalp lotion: potent.</p>
            </section>
      </section>







      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

        
          <h3>Specific side effects</h3>
              <p>
                <strong>commonOrVeryCommon:</strong> headache,
              </p>
              <p>
                <strong>uncommon:</strong> dyspepsia, palpitation, weight gain,
              </p>
        
            <section class="advice">
                <h3>Nasal ulceration</h3>
              <p>Nasal ulceration occurs commonly with preparations containing mometasone furoate.</p>
            </section>
        
      </section>


      <section class="tab-pane" id="patientAndCarerAdvice">
        <h2>Advice for patients and carers</h2>

            <section class="generalPatientAdvice">
              <h3 class="specificity">With <ph outputclass="route">topical</ph> use</h3>
              <p>Patients and carers should be advised on the application of topical mometasone. </p>
            </section>
            <section class="patientResources">
              <h3 class="specificity">In children</h3>
                <p class="title">Medicines for Children leaflet: Mometasone furoate inhaler for asthma prevention (prophylaxis)</p>
              <p>
            <xref format="html" href="http://www.medicinesforchildren.org.uk/mometasone-furoate-inhaler-for-asthma-prevention-prophylaxis">www.medicinesforchildren.org.uk/mometasone-furoate-inhaler-for-asthma-prevention-prophylaxis</xref>
            </p>
            </section>
            <section class="patientResources">
              <h3 class="specificity">When used by <ph outputclass="route">inhalation</ph></h3>
              <p>Patients or carers should be given advice on how to administer mometasone by inhaler. With high doses, a steroid card should be supplied.</p>
            </section>
      </section>

      <section class="tab-pane" id="nationalFunding">
        <h2>National funding/access decisions</h2>

      </section>





      <section class="tab-pane" id="unlicensedUse">
        <h2>Unlicensed use</h2>

            <section class="unlicensedUse">
              <h3 class="specificity">With <ph outputclass="route">topical</ph> use in children</h3>
              <p>Not licensed for use in children under 2 years.</p>
            </section>
      </section>










      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of MOMETASONE FUROATE</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        
          <strong>Forms available from special-order manufacturers include: </strong>
            ointment,

            <div id="PHP76136"><a href="../medicinalForm/PHP76136.html" data-target="#PHP76136" data-action="load">Inhalation powder</a></div>
            <div id="PHP76124"><a href="../medicinalForm/PHP76124.html" data-target="#PHP76124" data-action="load">Liquid</a></div>
            <div id="PHP76118"><a href="../medicinalForm/PHP76118.html" data-target="#PHP76118" data-action="load">Cream</a></div>
            <div id="PHP76143"><a href="../medicinalForm/PHP76143.html" data-target="#PHP76143" data-action="load">Ointment</a></div>
            <div id="PHP76128"><a href="../medicinalForm/PHP76128.html" data-target="#PHP76128" data-action="load">Spray</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
